companydata.dkcompanydata.dk

APO PHARM ApS: Financial statements 2020

CVR: 15226072

Source: annual report 2020, Danish Business Authority

01/07/2019 – 30/06/2020

APO PHARM ApS (CVR 15226072) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 2,124,103 and a net result of DKK 678,351 compared with DKK 748,302 the year before. That is an increase of 18.1% compared with the year before. Equity in the 2020 report amounted to DKK 1,071,748. The solvency ratio was 45.8%. The company had 6 employees in the financial year.

Gross Profit
DKK 2,124,103
Profit/Loss
DKK 678,351
Equity
DKK 1,071,748
Total Assets
DKK 2,338,201
Employees
6

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-2.1 mio.678 t.1.1 mio.6
2019-1.8 mio.748 t.1.1 mio.5
2018-1.2 mio.66 t.345 t.5
2017-1 mio.52 t.279 t.-
2016-939 t.54 t.227 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is APO PHARM ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Marthine Overgaard Bertelsen leaves the board of APO PHARM ApSNov 12, 2020

As of November 12, 2020, Marthine Overgaard Bertelsen has left the board of directors of APO PHARM ApS.

About APO PHARM ApS

APO PHARM ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 1991. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Helge Larsen. The board consists of Hanne Vesti Petersen and Helge Larsen. The company is owned by VESTI LARSEN ApS. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 1,481,073 and a net result of DKK 26,824 compared with DKK 121,257 the year before. Equity in the 2025 report amounted to DKK 332,307.

Source: annual report 2025, Danish Business Authority